[1]于承仟,徐学刚,李远宏.苯乙基间苯二酚的研究应用进展[J].中国皮肤性病学杂志,2020,(06):692-695.[doi:10.13735/j.cjdv.1001-7089.201909154]
 YU Chengqian,XU Xuegang,LI Yuanhong.Research Progress of Phenylethyl Resorcinol[J].The Chinese Journal of Dermatovenereology,2020,(06):692-695.[doi:10.13735/j.cjdv.1001-7089.201909154]
点击复制

苯乙基间苯二酚的研究应用进展
分享到:

《中国皮肤性病学杂志》[ISSN:1001-7089/CN:61-1197/R]

卷:
期数:
2020年06期
页码:
692-695
栏目:
综述
出版日期:
2020-06-01

文章信息/Info

Title:
Research Progress of Phenylethyl Resorcinol
文章编号:
1001-7089(2020)06-0692-04
作者:
于承仟 徐学刚 李远宏
中国医科大学附属第一医院,辽宁 沈阳 110001
Author(s):
YU ChengqianXU XuegangLI Yuanhong
(No.1 Hospital of China Medical University,Shenyang 110001,China)
关键词:
苯乙基间苯二酚 酪氨酸酶抑制剂 抗氧化
Keywords:
Phenylethyl resorcinol Tyrosinase inhibitor Antioxidant
分类号:
R 751; R 914
DOI:
10.13735/j.cjdv.1001-7089.201909154
文献标志码:
A
摘要:
苯乙基间苯二酚是一种强效的酪氨酸酶抑制剂,并且具有较强的抗氧化能力,于2012年被美国国家食品药品监督管理局正式批准作为化妆品原料使用。本文将苯乙基间苯二酚的理化性质、生理活性及作用机制、研究应用进展、安全性等作一归纳概述,为其临床应用提供参考。
Abstract:
Phenylethyl resorcinol is a potent inhibitor of tyrosinase with strong antioxidant activity.It was officially approved by the National Food and Drug Administration as a cosmetic raw material in 2012.The article summarizes physicochemical properties,physiological activity,mechanism of action,research and application progress and safety of phenylethyl resorcinol,thereby providing reference for its clinical application.

参考文献/References:

[1] Yamaguchi Y,Brenner M,Hearing VJ.The regulation of skin pigmentation[J].J Biol Chemi,2007,282(38):27557-27561.
[2] Schmaus G,Vielhaber G,Jacobs K,et al.4-(1-Phenylethyl)1,3-benzenediol:a new highly potent lightening agent[J].J Cosmet Sci,2006,57(2):197-198.
[3] Chang TS.An updated review of tyrosinase inhibitors[J].Int J Mol Sci,2009,10(6):2440-2475.
[4] Fan H,Liu G,Huang Y,et al.Development of a nanostructured lipid carrier formulation for increasing photostability and water solubility of phenylethyl resorcinol[J].Appl Surf Sci,2014,288(1):193-200.
[5] Köpke D,Müller RH,Pyo SM.Phenylethyl resorcinol smartLipids for skin brightening-Increased loading & chemical stability[J].Eur J Pharm Sci,2019,137(1):104992.
[6] Pillaiyar T,Manickam M,Jung SH.Recent development of signaling pathways inhibitors of melanogenesis[J].Cellular Signal,2017,12(40):99-115.
[7] Olivares C,Solano F.New insights into the active site structure and catalytic mechanism of tyrosinase and its related proteins[J].Pigment Cell Melanoma Res,2009,22(6):750-760.
[8] Costin GE,Hearing VJ.Human skin pigmentation:melanocytes modulate skin color in response to stress[J].FASEB J,2007,21(4):976-994.
[9] 杨鹏欣,刘蕾,马来记,等.黑素合成相关MITF基因及其表达研究概况[J].日用化学工业,2017,47(1):46-51.
[10] 刘园园,李欣,靳佳慧,等.苯乙基间苯二酚对UVB诱导的人皮肤黑素细胞氧化模型损伤的保护作用及其机制[J].中国皮肤性病学杂志,2018,32(10):1107-1112.
[11] Kang M,Park SH,Park SJ,et al.p44/42 MAPK signaling is a prime target activated by phenylethyl resorcinol in its anti-melanogenic action[J].Phytomedicine,2019,58:152877.
[12] 郝谜谜,王艳,刘园园,等.苯乙基间苯二酚抑制黑色素形成的机理研究[J].日用化学工业,2018,48(5):293-298.
[13] Gold MH,Biron J.Efficacy of a novel hydroquinone-free skin-brightening cream in patients with melasma[J].J Cosmet Dermatol,2011,10(3):189-196.
[14] Dreher F,Draelos ZD,Gold MH,et al.Efficacy of hydroquinone-free skin-lightening cream for photoaging[J].J Cosmet Dermatol,2013,12(1):12-17.
[15] Sorg O,Kasraee B,Salomon D,et al.The combination of a retinoid,a phenolic agent and an antioxidant improves tolerance while retaining an optimal depigmenting action in reconstructed epidermis[J].Dermatology,2013,227(2):150-156.
[16] Cameli N,Abril E,Agozzino M,et al.Clinical and instrumental evaluation of the efficacy of a new depigmenting agent containing a combination of a retinoid,a phenolic agent and an antioxidant for the treatment of solar lentigines[J].Dermatology,2015,230(4):360-366.
[17] 朱静,张汝芝,李洪洲,等.烟酰胺对角质形成细胞吞噬黑素体抑制的实验观察[J].中国皮肤性病学杂志,2014,28(11):1117-1120.
[18] 林茂,卢珊珊,齐晓怡,等.姜黄素对正常人表皮黑素细胞黑素生成的影响[J].中国中西医结合皮肤性病学杂志,2011,10(1):5-7.
[19] 周丹丹,贺立平,刘婷婷,等.不同配方化妆品对皮肤美白作用的初步研究[J].香料香精化妆品,2016,2(1):45-49.
[20] 赵仕芝.复合美白剂脂质纳米粒的制备及美白性能评估[D].东南大学,2017.
[21] Pastor-Nieto MA,Sánchez-Pedreño P,Martínez-Menchón T,et al.Allergic contact dermatitis caused by phenylethyl resorcinol,a skin-lightening agent contained in a sunscreen[J].Contact Dermatitis,2016,75(4):250-253.
[22] Gohara M,Yagami A,Suzuki K,et al.Allergic contact dermatitis caused by phenylethyl resorcinol [4-(1-phenylethyl)-1,3-benzenediol],a skin-lightening agent in cosmetics[J].Contact Dermatitis,2013,69(5):319-320.

备注/Memo

备注/Memo:
[基金项目] 中国国家重点研究开发计划(No.2016YFC0901504); 111项目(D18011)
[通信作者] 李远宏,E-mail:13804003841@139.com
[Corresponding author]LI Yuanhong,E-mail:13804003841@139.com
更新日期/Last Update: 2020-06-05